| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
American Imaging Management, Inc. is a Deerfield, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Jefferson Medical is a Oak Ridge, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cardiva Medical, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sunnyvale, CA. To find more information about Cardiva Medical, Inc., please visit www.cardivamedical.com
Medical Instrument Development Laboratories is a San Leandro, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.